Type 2 diabetes cases up 40% in Scotland

pharmafile | February 11, 2020 | News story | Manufacturing and Production Type 1 diabetes, diabetes, diabetes obesity, obesity, type 2 diabetes 

According to a new study, Scotland’s cases of type 2 diabetes has increased by 40% over the last 10 years.

Diabetes Scotland’s figures show cases rose from 190,772 to 267,615 between 2008 and 2018. They also estimate that 26,347 people are living with the condition.

Diabetes Scotland said the figures prove this is now an urgent public health crisis. Angela Mitchel, the Director of the organization, said: “Solving the crisis depends on decisive action led by both the UK and Scottish governments, supported by industry and delivered across our society.

“We must create healthy environments which support people to make healthy choices. This includes mandating industry to make food and drinks healthier and addressing the marketing and promotion of unhealthy foods. We welcome the action from the Scottish government in developing the Type 2 Diabetes Framework but we must ensure that there is long-term support people in Scotland to live healthier lives.”

People with Type 2 diabetes face a greatest chance of premature death than the general population, by about 50%. Heart disease is a common complication, with overweight type 2 diabetics affected in particular.

Type 2 diabetes is a chronic condition associated with both obesity and is particularly common in older people, with excessive weight being responsible for 80%85% of people developing the condition.

Conor Kavanagh

Related Content

FDA approves new insulin pump and algorithm software for enhanced automated insulin delivery

The US Food and Drug Administration (FDA) has announced that it has cleared the Beta …


Eli Lilly’s Type 2 diabetes drug outperforms semaglutide in trials

Eli Lilly has announced that the SURPASS-2 clinical trial has shown tirzepatide achieved superior HbA1C …

NHS to pilot artificial pancreas for type 1 diabetes

The NHS has announced that artificial pancreases will be available to patients with type 1 …

Latest content